Interlakes Oncology Hematology, PC

Geneva, New York 14456

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed